Skip to main content

Dreyer Scott's Form 4 filing

Collegium Pharmaceutical, Inc (COLL) · filed May 28, 2024

Accession no.
0001062993-24-011338
Filed
May 28, 2024
Trade date
May 23-24, 2024
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.66M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dreyer ScottCIK 0001746251Officer (EVP & Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 23, 2024Common StockMOption exerciseAcquired+51,209$24.03+$1,230,552.27190,127Direct
May 23, 2024Common StockSSaleDisposed−51,209$33.82−$1,731,888.38138,918Direct
May 24, 2024Common StockMOption exerciseAcquired+23,791$24.03+$571,697.73162,709Direct
May 24, 2024Common StockSSaleDisposed−56,807$33.98−$1,930,301.86105,902Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 23, 2024Common StockMOption exerciseDisposed−51,209$0.00$023,791Direct
May 24, 2024Common StockMOption exerciseDisposed−23,791$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)